Literature DB >> 11899174

Renal perfusion during thoracoabdominal aortic operations: cold crystalloid is superior to normothermic blood.

Cüneyt Köksoy1, Scott A LeMaire, Patrick E Curling, Steven A Raskin, Zachary C Schmittling, Lori D Conklin, Joseph S Coselli.   

Abstract

BACKGROUND: Renal failure remains a common complication of thoracoabdominal aortic aneurysm repair. The purpose of this randomized clinical trial was to compare two methods of selective renal perfusion--cold crystalloid perfusion versus normothermic blood perfusion--and determine which technique provides the best kidney protection during thoracoabdominal aortic aneurysm repair.
METHODS: Thirty randomized patients undergoing Crawford extent II thoracoabdominal aortic aneurysm repair with left heart bypass had renal artery perfusion with either 4 degrees C Ringer's lactate solution (14 patients) or normothermic blood from the bypass circuit (16 patients). Acute renal dysfunction was defined as an elevation in serum creatinine level exceeding 50% of baseline within 10 postoperative days.
RESULTS: One death occurred in each group. One patient in the blood perfusion group experienced renal failure requiring hemodialysis. Ten patients (63%) in the blood perfusion group and 3 patients (21%) in the cold crystalloid perfusion group experienced acute renal dysfunction (p = 0.03). Multivariable analysis confirmed that the use of cold crystalloid perfusion was independently protective against acute renal dysfunction (p = 0.02; odds ratio, 0.133).
CONCLUSIONS: When using left heart bypass during repair of extensive thoracoabdominal aortic aneurysms, selective cold crystalloid perfusion offers superior renal protection when compared with conventional normothermic blood perfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11899174     DOI: 10.1016/s0003-4975(01)03575-5

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  18 in total

1.  Aortic dimensions and the risk of dissection.

Authors:  Raimund Erbel; Holger Eggebrecht
Journal:  Heart       Date:  2006-01       Impact factor: 5.994

Review 2.  [Radical and partial nephrectomy for RCC: laparoscopy or open surgery].

Authors:  G Janetschek
Journal:  Urologe A       Date:  2007-05       Impact factor: 0.639

3.  Thoracoabdominal aortic aneurysm repair with a branched graft.

Authors:  Kim I de la Cruz; Scott A LeMaire; Scott A Weldon; Joseph S Coselli
Journal:  Ann Cardiothorac Surg       Date:  2012-09

4.  Results of open thoracoabdominal aortic aneurysm repair.

Authors:  Scott A LeMaire; Matt D Price; Susan Y Green; Samantha Zarda; Joseph S Coselli
Journal:  Ann Cardiothorac Surg       Date:  2012-09

5.  Thoracoabdominal aortic aneurysm.

Authors:  John R Frederick; Y Joseph Woo
Journal:  Ann Cardiothorac Surg       Date:  2012-09

6.  Extent II repair of thoracoabdominal aortic aneurysm secondary to chronic dissection.

Authors:  Joseph S Coselli; Scott A LeMaire; Scott A Weldon
Journal:  Ann Cardiothorac Surg       Date:  2012-09

7.  Therapeutic distant organ effects of regional hypothermia during mesenteric ischemia-reperfusion injury.

Authors:  Rachel J Santora; Mihaela L Lie; Dmitry N Grigoryev; Omer Nasir; Frederick A Moore; Heitham T Hassoun
Journal:  J Vasc Surg       Date:  2010-08-03       Impact factor: 4.268

Review 8.  Therapeutic hypothermia and prevention of acute kidney injury: a meta-analysis of randomized controlled trials.

Authors:  Paweena Susantitaphong; Mansour Alfayez; Abraham Cohen-Bucay; Ethan M Balk; Bertrand L Jaber
Journal:  Resuscitation       Date:  2011-10-06       Impact factor: 5.262

Review 9.  State-of the-art review on the renal and visceral protection during open thoracoabdominal aortic aneurysm repair.

Authors:  Karl Waked; Marc Schepens
Journal:  J Vis Surg       Date:  2018-02-08

Review 10.  [Anesthesiologic procedure for elective aortic surgery].

Authors:  J Knapp; M Bernhard; H Rauch; A Hyhlik-Dürr; D Böckler; A Walther
Journal:  Anaesthesist       Date:  2009-11       Impact factor: 1.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.